476 related articles for article (PubMed ID: 27658772)
1. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.
Merry TL; Tran M; Dodd GT; Mangiafico SP; Wiede F; Kaur S; McLean CL; Andrikopoulos S; Tiganis T
Diabetologia; 2016 Dec; 59(12):2632-2644. PubMed ID: 27628106
[TBL] [Abstract][Full Text] [Related]
3. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2013 Feb; 97(2):326-31. PubMed ID: 23269818
[TBL] [Abstract][Full Text] [Related]
4. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
[TBL] [Abstract][Full Text] [Related]
5. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
6. Nuciferine protects bovine hepatocytes against free fatty acid-induced oxidative damage by activating the transcription factor EB/peroxisome proliferator-activated receptor γ coactivator 1 alpha pathway.
Fang Z; Jiang X; Wang S; Tai W; Jiang Q; Loor JJ; Yu H; Hao X; Chen M; Shao Q; Song Y; Lei L; Liu G; Du X; Li X
J Dairy Sci; 2024 Jan; 107(1):625-640. PubMed ID: 37709032
[TBL] [Abstract][Full Text] [Related]
7.
Herrera-Marcos LV; Sancho-Knapik S; Gabás-Rivera C; Barranquero C; Gascón S; Romanos E; Martínez-Beamonte R; Navarro MA; Surra JC; Arnal C; García-de-Jalón JA; Rodríguez-Yoldi MJ; Tena-Sempere M; Sánchez-Ramos C; Monsalve M; Osada J
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E249-E261. PubMed ID: 31846369
[TBL] [Abstract][Full Text] [Related]
8. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
9. The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease.
Chimienti G; Orlando A; Russo F; D'Attoma B; Aragno M; Aimaretti E; Lezza AMS; Pesce V
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573421
[TBL] [Abstract][Full Text] [Related]
10. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
[TBL] [Abstract][Full Text] [Related]
12. Hepatic PGC-1α has minor regulatory effect on the liver transcriptome and metabolome during high fat high fructose diet and exercise training.
Rasmussen MK; Thøgersen R; Horsbøl Lindholm P; Bertram HC; Pilegaard H
Gene; 2023 Jan; 851():147039. PubMed ID: 36368573
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
14. RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.
Han YH; Kim HJ; Kim EJ; Kim KS; Hong S; Park HG; Lee MO
Antioxid Redox Signal; 2014 Nov; 21(15):2083-94. PubMed ID: 24597775
[TBL] [Abstract][Full Text] [Related]
15. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
16. (-)-Hydroxycitric Acid Alleviates Oleic Acid-Induced Steatosis, Oxidative Stress, and Inflammation in Primary Chicken Hepatocytes by Regulating AMP-Activated Protein Kinase-Mediated Reactive Oxygen Species Levels.
Li L; Chu X; Yao Y; Cao J; Li Q; Ma H
J Agric Food Chem; 2020 Oct; 68(40):11229-11241. PubMed ID: 32940033
[TBL] [Abstract][Full Text] [Related]
17. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.
Xu MJ; Cai Y; Wang H; Altamirano J; Chang B; Bertola A; Odena G; Lu J; Tanaka N; Matsusue K; Matsubara T; Mukhopadhyay P; Kimura S; Pacher P; Gonzalez FJ; Bataller R; Gao B
Gastroenterology; 2015 Oct; 149(4):1030-41.e6. PubMed ID: 26099526
[TBL] [Abstract][Full Text] [Related]
18. Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes.
Chen Y; Mu P; He S; Tang X; Guo X; Li H; Xu H; Woo SL; Qian X; Zeng L; Wu C
Nutr Res; 2013 Apr; 33(4):332-9. PubMed ID: 23602251
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
20. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.
Sookoian S; Rosselli MS; Gemma C; Burgueño AL; Fernández Gianotti T; Castaño GO; Pirola CJ
Hepatology; 2010 Dec; 52(6):1992-2000. PubMed ID: 20890895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
